Trump signs ‘Most Favored Nation’ order to cut drug prices

Описание: President Trump signed a sweeping executive order aimed at reducing prescription drug costs in the U.S., calling on pharmaceutical companies to either voluntarily lower their prices or face federal intervention. The order directs the Department of Health and Human Services to negotiate directly with drug manufacturers over the next 30 days. If those talks fail, the administration plans to implement a "most favored nation" policy—tying U.S. drug prices to the lower rates paid in peer countries like Canada, France, and the U.K.

Dr. Swapna Reddy, Assistant Dean and Clinical Associate Professor at ASU’s College of Health Solutions, joined “Arizona Horizon” to break down the implications of this executive order. She explains the complexity of drug pricing and the challenges in applying models from countries with nationalized healthcare systems. Dr. Reddy emphasizes that while the goal of lowering drug prices is widely supported, the path to achieving it in the U.S. is far more nuanced than simply adopting international benchmarks.